Thomas Pendergast, MD
Anesthesiology · Terre Haute, INNPI 1407849094
Payments from drug & device makers
What this record shows
28 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 37.1% of the total. Reporting peaked in 2023 at $3,580 and has fallen 76.2% since, to $854 in 2025. Among anesthesiology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $54.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Relievant Medsystems, Inc.$1K
- Abbott$781
- Medtronic$743
- Vertos Medical, Inc.$712
- Boston Scientific$411
- plus $1K from 22 others
What the payments were for
- Travel & lodging$3,45442%
- Food & beverage$4,79358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 30 | $3,059 |
| Relievant Medsystems, Inc. | 7 | $1,419 |
| Abbott | 25 | $781 |
| Medtronic(2 entities) | 18 | $743 |
| Vertos Medical, Inc. | 7 | $712 |
| Boston Scientific | 16 | $411 |
| MML US, Inc. | 7 | $389 |
| Alkermes, Inc. | 5 | $100 |
| Lilly USA, LLC | 4 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| AbbVie | 3 | $46 |
| Radius Health, Inc. | 3 | $45 |
| Amgen | 3 | $43 |
| IBSA Pharma Inc. | 2 | $41 |
| AstraZeneca | 2 | $33 |
| Lundbeck LLC | 2 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Vertex | 1 | $23 |
| Averitas Pharma Inc. | 1 | $22 |
| Novo Nordisk | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Si-bone, Inc. | 1 | $19 |
| Painteq LLC | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,677
- Evoke SCS$2,292
- mild Device Kit$509
- Evoke$347
- ReActiv8$257
- INTELLIS ADAPTIVESTIM$196
- GENERAL PAIN MANAGEMENT$189
- PROCLAIM$136
- Proclaim Family of SCS IPGs$106
- SYNCHROMEDII$101
How this compares
$8,246 in reported general payments places this provider in the 95th percentile of 1,203 anesthesiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 46 | $203 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $72 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Terre Haute
- Jose DavidTerre Haute$2K
- Kenneth PrimmCrawfordsville$1M
- Brian SchmutzlerIndianapolis$384K
- Pieter VreedeRushville$379K
- Louis BojrabIndianapolis$130K
- Stephen StitleIndianapolis$109K
- Jerome AdamsMuncie$85K
- Lucas MitchelIndianapolis$61K
- David AdamsIndianapolis$19K
- Joseph RichardsonIndianapolis$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.